| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5680619 | Medicina Clínica | 2017 | 6 Pages |
Abstract
Suspending vitamin K antagonists with no bridging therapy performed in patients with a low thromboembolic risk does not expose such patients to a significant risk of embolic events.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Ana Florencia Becerra, MarÃa Teresita Cornavaca, José Ignacio Revigliono, Alejandro Contreras, Ricardo Albertini, Aldo Hugo Tabares,